Albemarle (ALB) Q3 2024 earnings summary

Executive summary

• Q3 2024 net sales declined 41% year-over-year to $1.35–$1.4 billion, driven by lower lithium prices, with Energy Storage and Specialties volumes up 16% and 4%, respectively.

• Net loss attributable to shareholders was $1.07–$1.1 billion, reflecting $861 million to $1.15 billion in pre-tax charges for asset write-offs and restructuring, mainly at Kemerton.

• Adjusted EBITDA was $211 million, down 68% year-over-year, but supported by higher volumes and cost reductions.

• Comprehensive cost and operating structure review underway, targeting $300–$400 million in annual cost savings and a 6–7% global workforce reduction, with nearly 1,000 roles eliminated in 2024.

• Announced a new integrated operating structure (excluding Ketjen) to drive agility and cost savings, effective November 2024.

Financial highlights

• Q3 2024 net sales: $1.35–$1.4 billion, down 41% year-over-year; adjusted EBITDA: $211 million (margin 15.6–16%).

• Net loss attributable to shareholders: $1.07–$1.11 billion (EPS: –$9.45); adjusted diluted EPS: –$1.55.

• Cash from operations reached $241 million in Q3, with year-to-date cash from operations at $701 million.

• Operating cash flow conversion exceeded 100% in Q3; full-year conversion expected at about 50%.

• Non-recurring and unusual items totaled $7.90–$7.91 per share in Q3 2024.

Outlook and guidance

• Full-year 2024 net sales expected at the lower end of $5.5–$6.2 billion, reflecting lower lithium prices.

• Full-year adjusted EBITDA expected in the middle of the $0.9–$1.2 billion range, aided by cost and productivity improvements.

• 2025 capital expenditures projected at $800–$900 million, down ~50% from 2024.

• Energy Storage volumes projected to grow 20–25% year-over-year; Q4 volumes expected to decline sequentially due to timing and planned outages.

• Additional restructuring charges of $30–$50 million for severance and $25–$30 million for other costs expected in Q4 2024.